Inflammatory Intermediates Produced by Tissues Encasing Silicone Breast Prostheses

References

• Coleman D. L., King R. N., Andrade J. D. The foreign body reaction: a chronic inflammatory response. J Biomed Mater Res. 1974; 23: 199–211
   Google Scholar
• Kossovsky N. The demise of the non-specific foreign body giant cell reaction. Trends in Polymer Science 1993; 1: 190–191
   Google Scholar
• Kossovsky N., Freiman C. J. Silicone breast implant pathology: clinical data and immunological consequences. Arch Path Lab Med. 1994; 118: 686–693
   PubMed Web of Science ®Google Scholar
• Munson A. E., White K. L., Jr, McCay J. A., Stern M. L. Immunotoxicity of Silicone in Female B6C3F1 Mice—180 Day Exposure (Protocol #Sil-180-I-SC). Report to National Toxicology Program. Submitted Nov 11 1992
   Google Scholar
• Smith D. J., Jr, Sazy J. A., Crissman J. D., et al. Immunogenic potential of carpal implants. J Surgical Research 1990; 48: 13–20
   PubMed Web of Science ®Google Scholar
• Wolf L. E., Lappe M., Peterson R. D., Ezrailson E. G. Human immune response to polydimethylsiloxane (silicone). Screening studies in a breast implant population. FASEB J. 1993; 7: 1265–1268
   PubMed Web of Science ®Google Scholar
• Kossovsky N., Zeidler M., Chun G., et al. Surface dependent antigens identified by high binding avidity of serum antibodies in a subpopulation of patients with breast prostheses. J of Appl Bio-mat. 1993; 4: 281–288
   Google Scholar
• Lake R. S., Radonovich M. F. Action of polydimethylsilixanes on the reticuloendothelial system of mice: basic cellular interactions and structure-activity relationships. Dow Corning Corporation Report 4509; 30 October 1975
   Google Scholar
• Bonfield T. L., Anderson J. M. Functional versus quantitative comparison of IL-1β from monocytes/macrophages on biomedical polymers. J Biomed Muter Res. 1993; 27: 1195–1199
   PubMed Web of Science ®Google Scholar
• McCauley R. L. In vitro alterations in human fibroblast behavior secondary to silicone. J Surg Res. 1990; 49: 103–109
   PubMed Web of Science ®Google Scholar
• Landon B. N., Dobke M. K., Grzybowski J., Virden C. P. Enhanced activity of lysosomal β galactosidase after silicone implantation: an experimental study in rats. J Lab Clin Med. 1993; 21: 742–750
   Google Scholar
• Kessler D. A. The basis of the FDA's decision on breast implants. N Engl J Med. 1992; 326: 1713–1715
   PubMed Web of Science ®Google Scholar
• Kossovsky N., Papasian N. Mammary implants. A clinical review. J Appl Biomat. 1992; 3: 239–242
   PubMedGoogle Scholar
• Goldring S. R., Schiller A. L., Roelke M., Rourke C. M., O'Neill D. A., Harris W. H. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am. 1983; 65: 575–583
   PubMed Web of Science ®Google Scholar
• Roitt I. M., Delves P. J. Interleukin 2. Encyclopedia of Immunology, IM Roitt, PJ Delves. Academic Press, San Diego 1992; 903–906
   Google Scholar
• Matsuda T., Kishimoto T. Interleukin 6. Encyclopedia of Immunology, IM Roitt, PJ Delves. Academic Press, San Diego 1992; 917–919
   Google Scholar
• Tracey K. J., Cerami A. Tumor necrosis factor α. Encyclopedia of Immunology, IM Roitt, PJ Delves. Academic Press, San Diego 1992; 1522–1524
   Google Scholar
• Tilg H., Nordberg J., Vogel W., et al. Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation. Transplantation 1992; 54: 142–146
   PubMed Web of Science ®Google Scholar
• Herlyn M., Malkowicz S. B. Biology of disease: regulatory pathways in tumor growth and invasion. Laboratory Investigation 1991; 65: 262–271
   PubMed Web of Science ®Google Scholar
• Snick J. V. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253–278
   PubMed Web of Science ®Google Scholar
• Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Hirano T. Interleukin-6 and autoimmunity and plasma cell neoplasias. Res in Immunology 1992; 143: 759–763
   PubMedGoogle Scholar
• Goldblum R. M., Pelley R. P., O'Donell A. A., Pyron D., Heggers J. P. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet 1992; 340: 510–513
   PubMed Web of Science ®Google Scholar
• House Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Operations. Is the FDA Protecting Patients from the Dangers of Silicone Breast Implants? 101st Cong., 2nd Session, 18 Dec 1990
   Google Scholar
• Sergott T. J., Limoli J. P., Baldwin C. M., Laub D. R. Human adjuvant disease; possible autoimmune disease after silicone implantation. Plast Reconstr Surg. 1986; 78: 104–114
   PubMed Web of Science ®Google Scholar
• Walsh F. W., Solomon D. A., Espinoza L. R., Adam G. D., Whitelocke J. E. Human adjuvant disease: a new cause of chylous effusion. Arch Intern Med. 1989; 149: 1194–1196
   PubMed Web of Science ®Google Scholar
• Varga J., Schumacher H. R., Jiminez S. A. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med. 1989; 111: 377–83
   PubMed Web of Science ®Google Scholar
• Boley W. F., Levier R. R. Immunological enhancing activities of organosilicon compounds and non-functional fluids, Dow Coming Report No. 4319, 2 October 1974. In: Dow Corning Corporation. Summary of Scientific Studies and Internal Company Documents Concerning Silicone Breast Implants. Released to the General Public. 1992, 10 February
   Google Scholar
• Kossovsky N., Heggers J. P., Robson M. C. Experimental demonstration of the immunogenicity of silicone-protein complexes. J Biomed Mat Res. 1987; 21: 1125–1133
   PubMed Web of Science ®Google Scholar
• Heggers J. P., Kossovsky N., Parsons R. W., Robson M. C., Pelly R. P., Raine T. J. Biocompatibility of silicone implants. Ann Plast Surg. 1983; 11: 38–45
   PubMed Web of Science ®Google Scholar
• Bridges A. J., Conley C., Wang G., Bums D. E., Vaset F. B. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 1993; 118(12)929–936
   PubMed Web of Science ®Google Scholar
• Smith K. Interleukin-2, Lymphocyte activation and effector functions. Current Opinions in Immunology 1992; 4: 271–276
   PubMedGoogle Scholar
• Scott P. IL-2: initiation cytokine for cell-mediated immunity. Science 1993; 260: 496–497
   PubMed Web of Science ®Google Scholar
• Cardona M. A., Simmons R. L., Kaplan S. TNF and IL-1 generation by human monocytes in response to biomaterial. J Biomed Mat Res. 1992; 26: 851–859
   PubMed Web of Science ®Google Scholar
• Dorr L. D., Bloebaum R., Emmanual J., Meldrum R. Histologic, biochemical, and ion analysis of tissue and fluids retrieved during total hip arthroplasty. Clin Orthop. 1990; 261: 82–95
   PubMed Web of Science ®Google Scholar
• Cila E., Alpaslan A. M., Melli M., Tokgozuglu A. M. Prostaglandin E2 activity in the synovial-like membrane. J Arthroplasty 1994; 9: 67–71
   Google Scholar
• Bonfield T. L., Colton E., Marchant R. E., Anderson J. M. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J Biomed Mater Res. 1992; 26: 837–850
   PubMed Web of Science ®Google Scholar